Specific batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets, made by Actavis (now Accord), are being recalled as a precautionary measure due to possible N‑nitrosodiethylamine (NDEA) contamination.
Further details of the alert, affected batches and actions to take are available on the MHRA website.